<VariationArchive RecordType="classified" VariationID="3269" VariationName="CDC73, 41-BP DUP/INS" VariationType="Duplication" Accession="VCV000003269" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-07-09" DateCreated="2018-07-27" MostRecentSubmission="2018-07-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18308" VariationID="3269">
      <GeneList>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+" />
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>CDC73, 41-BP DUP/INS</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q25-q31</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>41-BP DUP/INS</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="607393.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not provide an HGVS expression for allelic variant 607393.0003.  If you can provide a publication documenting this allele, please contact us.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="CDC73, 41-BP DUP/INS AND Hyperparathyroidism 2 with jaw tumors" Accession="RCV000003426" Version="3">
        <ClassifiedConditionList TraitSetID="833">
          <ClassifiedCondition DB="MedGen" ID="C1704981">Hyperparathyroidism 2 with jaw tumors</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-07-27" MostRecentSubmission="2018-07-27">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12434154</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5289" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyperparathyroidism 2</ElementValue>
                <XRef ID="Hyperparathyroidism+2/8598" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 2 with jaw tumors</ElementValue>
                <XRef ID="MONDO:0007768" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPT-JT</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HRPT2</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10829" />
                <XRef ID="10829" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99880" DB="Orphanet" />
              <XRef ID="C1704981" DB="MedGen" />
              <XRef ID="MONDO:0007768" DB="MONDO" />
              <XRef Type="MIM" ID="145001" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23584" SubmissionDate="2010-12-30" DateLastUpdated="2018-07-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607393.0003_HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" title="CDC73, 41-BP DUP/INS_HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" />
        <ClinVarAccession Accession="SCV000023584" DateUpdated="2018-07-27" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a kindred with hyperparathyroidism-jaw tumor syndrome (HRPT2; 145001), Carpten et al. (2002) found affected individuals had a 41-bp duplication/insertion in exon 1 of the HRPT2 gene, causing frameshift.</Attribute>
              <Citation>
                <ID Source="PubMed">12434154</ID>
              </Citation>
              <XRef DB="OMIM" ID="145001" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDC73" />
          </GeneList>
          <Name>CDC73, 41-BP DUP/INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">41-BP DUP/INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607393.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23584" TraitType="Disease" MappingType="Name" MappingValue="HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1704981" Name="Hyperparathyroidism 2 with jaw tumors" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

